Targeted reproductive management for lactating Holstein cows: Reducing the reliance on exogenous reproductive hormones.


Journal

Journal of dairy science
ISSN: 1525-3198
Titre abrégé: J Dairy Sci
Pays: United States
ID NLM: 2985126R

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 17 08 2022
accepted: 16 02 2023
medline: 23 10 2023
pubmed: 23 6 2023
entrez: 22 6 2023
Statut: ppublish

Résumé

Adoption of automated monitoring devices (AMD) affords the opportunity to tailor reproductive management according to the cow's needs. We hypothesized that a targeted reproductive management (TRM) would reduce the use of reproductive hormones while increasing the percentage of cows pregnant 305 d in milk (DIM). Holstein cows from 2 herds (n = 1,930) were fitted with an AMD at 251.0 ± 0.4 d of gestation. Early-postpartum estrus characteristics (EPEC; intense estrus = heat index ≥70; 0 = minimum, 100 = maximum) of multiparous cows were evaluated at 40 (herd 1) or 41 (herd 2) DIM and EPEC of primiparous cows were evaluated at 54 (herd 1) or 55 (herd 2) DIM. Control cows received the first artificial insemination at fixed time (TAI; primiparous, herd 1 = 82 and herd 2 = 83 DIM; multiparous, herd 1 = 68 and herd 2 = 69 DIM) following the Double-Ovsynch (DOV) protocol. Cows enrolled in the TRM treatment were managed as follows: (1) cows with at least one intense estrus were inseminated upon AMD detected estrus for 42 d and, if not inseminated, were enrolled in the DOV protocol; and (2) cows without an intense estrus were enrolled in the DOV protocol at the same time as cows in the control treatment. Control cows were re-inseminated based on visual or patch aided detection of estrus, whereas TRM cows were re-inseminated as described for control cows with the aid of the AMD. Cows received a GnRH injection 27 ± 3 d after insemination and, if diagnosed as nonpregnant, completed the 5-d Cosynch protocol and received TAI 35 ± 3 d after insemination. Among cows in the TRM treatment, 55.8 and 42.9% of primiparous and multiparous cows, respectively, received the first insemination in spontaneous estrus. The interaction between treatment and parity affected pregnancy 67 d after the first AI (primiparous: control = 37.6%, TRM = 27.4%; multiparous: control = 41.0%, TRM = 44.7%). The TRM treatment increased re-insemination in estrus (control = 48.3%, TRM = 70.5%). Pregnancy 67 d after re-inseminations tended to be affected by the interaction between treatment and EPEC (no intense estrus: control = 25.3%, TRM = 32.0%; intense estrus: control = 32.9%, TRM = 32.2%). The interaction between treatment and EPEC affected pregnancy by 305 DIM (no intense estrus: control = 80.8%, TRM = 88.2%; intense estrus: control = 87.1%, TRM = 86.1%). Treatment did not affect the number of reproductive hormone treatments among cows that had not had an intense estrus (control = 10.5 ± 0.3, TRM = 9.1 ± 0.2 treatments/cow), but cows in the TRM treatment that had an intense estrus received fewer reproductive hormone treatments than cows in the control treatment (2.0 ± 0.1 vs. 9.6 ± 0.2 treatments/cow). Selecting multiparous cows for first AI in estrus based on EPEC reduced the use of reproductive hormones without impairing the likelihood of pregnancy to first AI. The use of AMD for re-insemination expedited the establishment of pregnancy among cows that did not display an intense estrus early postpartum.

Identifiants

pubmed: 37349211
pii: S0022-0302(23)00355-7
doi: 10.3168/jds.2022-22666
pii:
doi:

Substances chimiques

Dinoprost B7IN85G1HY
Gonadotropin-Releasing Hormone 33515-09-2
Progesterone 4G7DS2Q64Y

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5788-5804

Informations de copyright

© 2023, The Authors. Published by Elsevier Inc. and Fass Inc. on behalf of the American Dairy Science Association®. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Auteurs

Tomas D Gonzalez (TD)

Department of Large Animal Clinical Sciences, University of Florida, Gainesville, FL 32610.

Luana Factor (L)

Department of Large Animal Clinical Sciences, University of Florida, Gainesville, FL 32610.

Ahmadreza Mirzaei (A)

Department of Large Animal Clinical Sciences, University of Florida, Gainesville, FL 32610.

Ana B Montevecchio (AB)

Department of Large Animal Clinical Sciences, University of Florida, Gainesville, FL 32610.

Segundo Casaro (S)

Department of Large Animal Clinical Sciences, University of Florida, Gainesville, FL 32610.

Victoria R Merenda (VR)

Department of Large Animal Clinical Sciences, University of Florida, Gainesville, FL 32610.

Jessica G Prim (JG)

Department of Large Animal Clinical Sciences, University of Florida, Gainesville, FL 32610.

Klibs N Galvão (KN)

Department of Large Animal Clinical Sciences, University of Florida, Gainesville, FL 32610.

Rafael S Bisinotto (RS)

Department of Large Animal Clinical Sciences, University of Florida, Gainesville, FL 32610.

Ricardo C Chebel (RC)

Department of Large Animal Clinical Sciences, University of Florida, Gainesville, FL 32610; Department of Animal Sciences, University of Florida, Gainesville, FL 32610. Electronic address: rcchebel@ufl.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH